ImmunityBio Competitors and Similar CompaniesClear all
ImmunityBio's competitors and similar companies include MABION.
 ImmunityBio ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Culver City, US HQ San Diego, US Woburn, US | Locations Konstantynów Łódzki, PL HQ |
Employees | Employees 16116% increase | Employees 95 |
Valuation ($) | Valuation ($) 4.3 b | Valuation ($) 21.7 m |
Financial | ||
Revenue (est.) | Revenue (est.) $113.3m (FY, 2025) | Revenue (est.) zł15.8m (FY, 2025) |
Cost of goods | Cost of goods $753k (FY, 2025) | Cost of goods zł24.1m (FY, 2025) |
Gross profit | Gross profit $112.5m (FY, 2025) | Gross profit (zł7.2m) (FY, 2025) |
Net income | Net income ($351.5m) (FY, 2025) | Net income (zł62.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
MABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View company